about
Nucleic acid sensing receptors in systemic lupus erythematosus: development of novel DNA- and/or RNA-like analogues for treating lupus.Class I/II hybrid inhibitory oligodeoxynucleotide exerts Th1 and Th2 double immunosuppression.Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerSynthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation.Classification, mechanisms of action, and therapeutic applications of inhibitory oligonucleotides for Toll-like receptors (TLR) 7 and 9.Modulating toll-like receptor 7 and 9 responses as therapy for allergy and autoimmunity.Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9.Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro.TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium.Characterization of suppressive oligodeoxynucleotides that inhibit Toll-like receptor-9-mediated activation of innate immunity.An immune regulatory CCT repeat containing oligodeoxynucleotide capable of causing hair loss in male mice.FC-98 regulates TLR9-mediated of CXCL-10 expression in dendritic cells via MAPK and STAT1 signaling pathway.Inhibition of a C-rich oligodeoxynucleotide on activation of immune cells in vitro and enhancement of antibody response in mice.Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees.Changes of KEAP1/NRF2 and IKB/NF-κB Expression Levels Induced by Cell-Free DNA in Different Cell Types.
P2860
Q34017633-AD9F5367-3AD8-4C8B-B967-BDA60378C344Q36889846-347E750C-5F14-4A77-83DA-4504689B8743Q37206862-17D47017-320D-483F-B3A2-1D8E7A19888FQ37277677-9E34C183-D32F-4FEF-A35D-6926264C32B3Q37426823-9EB690FB-93EE-442E-B47B-DBFF04090738Q37758263-3461DDF4-DEBF-4A49-A358-BD575CFCD394Q37956536-471C1D82-ED60-4A7A-9821-82C04C217DF0Q38333329-634CF668-0B04-468C-853A-9DC5989E6842Q38802341-AFBC8F9F-B1F0-4D8E-97F8-DE6B7076FA72Q39910223-A5F75918-881D-4C38-B66A-96690A866535Q40062305-6A1F89DA-C17E-4D45-BA31-8C1D77C89D86Q40110544-9E5AC446-2563-40B7-84CA-64FE7CF9E7ABQ42181542-E5F0D3BD-5C86-4E4D-B95A-C23024074A5FQ42964283-EB342561-E6AF-461B-ACDB-67E28795646CQ54443051-3CB3A669-66A4-4CB8-8ABC-F52DEF06260CQ55053015-D25B2B39-E7AB-4A73-A0BB-38B3BB1EA7FE
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
DNA motifs suppressing TLR9 responses.
@en
type
label
DNA motifs suppressing TLR9 responses.
@en
prefLabel
DNA motifs suppressing TLR9 responses.
@en
P2093
P1476
DNA motifs suppressing TLR9 responses
@en
P2093
Angela Trieu
Jasmyn A Dunn
Katryn J Stacey
Matthew J Sweet
P304
P356
10.1615/CRITREVIMMUNOL.V26.I6.50
P577
2006-01-01T00:00:00Z